Cargando…
Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial)
INTRODUCTION: Infants born late preterm (34+0 to 36+6 weeks’ gestational age) have frequent episodes of intermittent hypoxaemia compared with term infants. Caffeine citrate reduces apnoea and intermittent hypoxaemia and improves long-term neurodevelopmental outcomes in infants born very preterm and...
Autores principales: | Oliphant, Elizabeth Anne, McKinlay, Christopher J D, McNamara, David G, Alsweiler, Jane Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577061/ https://www.ncbi.nlm.nih.gov/pubmed/33082191 http://dx.doi.org/10.1136/bmjopen-2020-038271 |
Ejemplares similares
-
Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial
por: Oliphant, Elizabeth Anne, et al.
Publicado: (2023) -
Correction: (Rad 8)Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial)
Publicado: (2020) -
Computer-determined dosage of insulin in the management of neonatal hyperglycaemia (HINT2): protocol of a randomised controlled trial
por: Alsweiler, Jane, et al.
Publicado: (2017) -
Different Approaches to requesting Consent for Routine data linkage in Neonatal follow-up (ACORN): protocol for a 2×2 factorial randomised trial
por: Harding, Jane E, et al.
Publicado: (2022) -
Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial
por: Laing, Don, et al.
Publicado: (2022)